Search results
Showing 586 to 600 of 1290 results for position
whereas micro-, small- and medium-sized organisations may not be in a position to fund external occupational health provision or...
Our quality standards set out priority areas for quality improvement in health, public health and social care.
Our experts can offer advice and support in contextualising our guidelines, or helping you adapt our content to your country or local context.
We want you to help NICE to develop our guidance for NHS and care services.
How to register as a stakeholder with NICE.
The NICE commercial liaison team aim to reduce the workload for the NHS and frontline staff by making commercial agreements more straightforward.
How to register as a stakeholder with NICE.
We want you to help NICE to develop our guidance for NHS and care services.
NICE guidance and standards support health professionals by providing evidence-based recommendations that enhance clinical decision-making and patient care.
NICE's guidance and advice can help you make the best use of resources and generate cost savings.
Using our content internationally. Includes information on fees and licensing agreements for both AI and non AI requests.
Evidence-based recommendations on erlotinib (Tarceva) and gefitinib (Iressa) for treating non-small-cell lung cancer after chemotherapy in adults.
Learn about NICE's proportionate approach to technology appraisals, which aims to streamline the evaluation process for new health technologies, ensuring timely access to innovative treatments while maintaining rigorous standards.
Our guidance helps you hand over care and ensure people are safely transitioned out of the virtual ward environment.
This resource is intended to demonstrate how our guidance can be used in the Care Quality Commission (CQC) assessment process.